Citadel Advisors »

Mineralys Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $996k 116k 8.60
2023-09-30 $177k 19k 9.51
2023-03-31 $3.0M 191k 15.66

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments
Walleye Trading Advisors

View all funds holding Mineralys Therapeutics